UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
(Address of Principal Executive Offices)
+
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Exchange Act
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
None | None | None |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On August 2, 2023, Avon Products, Inc. announced early tender results in connection with its previously announced offer to purchase for cash any and all of its outstanding 6.950% Notes due 2043 (the “Notes”) and related solicitation of consents to the holders of the Notes to adopt certain amendment to the indenture governing the Notes. A copy of the press release is being furnished as Exhibit 99.1 herewith.
This Current Report on Form 8-K does not constitute an offer to sell, or a solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful.
The information in this Item 8.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “1934 Act”), nor shall it be deemed “incorporated by reference” into any filing under the Securities Act of 1933, as amended, or the 1934 Act, except as may be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) | Exhibits. |
Exhibit No. |
Description | |
99.1 | Avon Products, Inc. Press Release titled “Avon Products, Inc. Announces Early Results of Tender Offer For Any And All of its Outstanding 6.950% Notes Due 2043 and Related Consent Solicitation,” dated August 2, 2023 | |
104 | Cover Page Interactive Data File (embedded in the cover page formatted in Inline XBRL). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 2, 2023
AVON PRODUCTS, INC. | ||
By: | /s/ Ginny Edwards | |
Name: Ginny Edwards | ||
Title: VP, General Counsel and Corporate Secretary |
Exhibit 99.1
AVON PRODUCTS, INC. ANNOUNCES EARLY RESULTS OF TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 6.950% NOTES DUE 2043 AND RELATED CONSENT SOLICITATION
London, United Kingdom, August 2, 2023 — Avon Products, Inc. (“Avon,” the “Company” or “we”) announced today the early tender results in connection with its previously announced offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 6.950% Notes due 2043 (the “Notes”) and related consent solicitation (the “Consent Solicitation”).
The early tender date for the Tender Offer (as amended on July 24, 2023) was 5:00 p.m., New York City time, August 2, 2023 (the “Early Tender Date”). According to information received from D.F. King & Co., Inc., the tender and information agent for the Tender Offer and Consent Solicitation (the “Tender and Information Agent”), as of 5:00 p.m., New York City time, on August 2, 2023, the Company had received Notes validly tendered and consents representing an aggregate principal amount equal to US$193,962,000 (or 89.76% of the aggregate principal amount outstanding of Notes as of the date of this press release) and, as announced on July 24, 2023, has obtained the Requisite Consents necessary to give effect to the Proposed Amendments. Consequently, as previously announced, the Company expects to execute the Twelfth Supplemental Indenture effecting the Proposed Amendments on or prior to the Early Settlement Date. The Twelfth Supplemental Indenture will become effective upon its execution and delivery by the Company and the Trustee but will not become operative until the Company has paid the Consent Payment in full.
The Notes that have been validly tendered cannot be withdrawn, except as may be required by applicable law. Holders who validly tendered their Notes at or prior to the Early Tender Date, in the manner described in the Offer to Purchase (as defined below), will be eligible to receive the Total Consideration, which includes the Early Tender Payment, plus any accrued interest, concurrently with payment for Notes tendered after the Early Tender Date and at or prior to the Expiration Date (as defined below) and accepted for purchase, on a single settlement date, expected to be on August 8, 2023, or as promptly as practicable thereafter.
The following table sets forth certain information relating to the Tender Offer:
Title of Security |
ISIN/CUSIP |
Principal Outstanding Amount |
Tender Offer Consideration(1) |
Early Tender Payment(1)(2) |
Total Consideration(1) |
6.950% Notes due 2043 | US054303AZ59/054303 AZ5 | U.S.$216,085,000 | U.S.$1,187.50 | U.S.$50.0 | U.S.$1,237.50 |
(1) | The amount o be paid for each U.S.$1,000 principal amount of Notes validly tendered (and not validly withdrawn) and accepted for purchase, excluding Accrued Interest (as defined in the Offer to Purchase), which will be paid in addition to the Tender Offer Consideration and, if applicable, the Early Tender Payment. |
(2) | Included in the Total Consideration. |
The Tender Offer and related Consent Solicitation will expire at 5:00 p.m., New York City time, on August 7, 2023, unless extended or earlier terminated by us (such time and date, as it may be extended or earlier terminated with respect to the Tender Offer, the “Expiration Date”).
Our obligation to purchase the Notes in the Tender Offer is conditioned on the satisfaction or waiver of certain conditions, including the Financing Condition, as described in the Offer to Purchase. The Financing Condition relates to intercompany financing received from one of our affiliates. Subject to the applicable law, we have the right, in our sole discretion, to amend or terminate the Tender Offer or the Consent Solicitation at any time, and we reserve the right, in our sole discretion, not to accept any tenders of Notes for any reason.
The terms and conditions of the Tender Offer and Consent Solicitation, as well as the Proposed Amendments, are described in the Offer to Purchase and Consent Solicitation Statement, dated July 11, 2023 (as it may be amended or supplemented, the “Offer to Purchase”). Copies of the Offer to Purchase are available to Holders from the Tender and Information Agent. Requests for copies of the Offer to Purchase should be directed to the Tender and
Information Agent in New York at +1 (800) 992-3086 (toll free) or +1 (212) 269-5550 (collect), or at avon@dfking.com. Capitalized terms used but not defined in this press release have the meaning given to them in the Offer to Purchase.
HSBC Securities (USA) Inc. and Mizuho Securities USA LLC are the Dealer Managers and Solicitation Agents in connection with the Tender Offer and Consent Solicitation. Questions regarding the Tender Offer and Consent Solicitation may be directed to HSBC Securities (USA) Inc. at +1 (888) HSBC-4LM (toll-free) or +1 (212) 525-5552 (collect), or to Mizuho Securities USA LLC at +1 (866) 271-7403 (toll-free) or +1 (212) 205-7736 (collect).
Neither the Offer to Purchase nor any related documents have been filed with or reviewed by any federal or state securities commission or regulatory authority of any country. No authority has passed upon the accuracy or adequacy of the Offer to Purchase or any related documents, and it is unlawful and may be a criminal offense to make any representation to the contrary.
The Tender Offer and Consent Solicitation are being made solely on the terms and conditions set forth in the Offer to Purchase. Under no circumstance shall this press release constitute an offer to purchase nor a solicitation of an offer to sell the Notes or any other securities or a solicitation of consents. The Tender Offer and Consent Solicitation are not being made to, nor will we accept tenders of Notes or delivery of consents from, Holders in any jurisdiction in which the Tender Offer and Consent Solicitation would not be in compliance with the securities or blue sky laws of such jurisdiction. No recommendation is made by us, the Dealer Managers or the Solicitation Agents as to whether Holders should tender their Notes or deliver consents. Holders should carefully read the Offer to Purchase and the related materials, because they contain important information, including the various terms and conditions of the Tender Offer and Consent Solicitation.
About Avon
For 130 years Avon has stood for women: providing innovative, quality beauty products which are primarily sold to women, through women. Millions of independent Representatives across the world sell iconic Avon brands such as Avon Color and ANEW through their social networks, building their own beauty businesses on a full- or part-time basis. Avon supports women’s empowerment, entrepreneurship and well-being and has donated over U.S.$1 billion to women’s causes through Avon and the Avon Foundation. Avon is a wholly owned subsidiary of Natura &Co Holding. To learn more, please visit Natura &Co Holding’s website at https://www.naturaeco.com/brands/avon-2/.
Forward-Looking Statements
Disclosures in this press release contain forward-looking statements. All statements, other than statements of historical facts, included in this press release that address activities, events or developments that management expects, believes or anticipates will or may occur in the future are forward-looking statements. Without limiting the generality of the foregoing, forward-looking statements contained in this press release specifically include statements regarding the making and consummation of the Tender Offer, the Consent Solicitation and the Financing Transaction (as defined in the Offer to Purchase), including the timing thereof, the Proposed Amendments and the execution of the Supplemental Indenture (as defined in the Offer to Purchase). These statements are based on certain assumptions made by Avon based on its management’s experience and perception of historical trends, current conditions, anticipated future developments and other factors believed to be appropriate. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Avon, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. These include risks set forth in reports filed by Natura &Co Holding with the Brazilian Securities Commission (Comissão de Valores Mobiliários) and the U.S. Securities and Exchange Commission (the “SEC”), and by Avon with the SEC. Any forward-looking statement applies only as of the date on which such statement is made and Avon does not intend to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.
Avon
Products, Inc.
c/o Natura &Co Holding S.A.
Investor Relations Team
ri@natura.net
Cover |
Aug. 02, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 02, 2023 |
Entity File Number | 1-4881 |
Entity Registrant Name | Avon Products, Inc. |
Entity Central Index Key | 0000008868 |
Entity Tax Identification Number | 13-0544597 |
Entity Incorporation, State or Country Code | NY |
Entity Address, Address Line One | Nunn Mills Road |
Entity Address, City or Town | Northampton |
Entity Address, Country | GB |
Entity Address, Postal Zip Code | NN1 5PA |
Country Region | 44 |
City Area Code | 1904 |
Local Phone Number | 232425 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
-8?20$3;8T.P6BP^0"X99K>]9!:G